​

Funding Round

Series A - Vicinitas Therapeutics

Series A - Vicinitas Therapeutics

Investment Firm

Overview

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

Announced Date

Jul 28, 2022

Closed on Date

Jul 29, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.

Deerfield

Deerfield

Deerfield is a debt and early_stage_venture firm.

Participant Investors

5

Investor Name
Participant InvestorThe Mark Foundation for Cancer Research
Participant InvestorDroia Ventures
Participant InvestorDeerfield
Participant InvestorAndreessen Horowitz
Participant InvestorGoogle Ventures

Round Details and Background

Vicinitas Therapeutics raised $65000000 on 2022-07-28 in Series A

Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 28, 2022
Series A - Vicinitas Therapeutics
6-65.0M

Recent Activity

There is no recent news or activity for this profile.